Lorazepam Injection shortage
Currently in ShortageLorazepam Injection is currently listed as Currently in Shortage in the FDA Drug Shortage Database. Reported reason: Demand increase for the drug.
Therapeutic category
Dosage form
Injection
Routes
INTRAMUSCULAR, INTRAVENOUS
Last updated
04/02/2026
Strength variants
- Not specified
Need sourcing help for Lorazepam Injection?
Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.
Connect with a sourcing partnerManufacturers reporting shortage
- Amphastar Pharmaceuticals, Inc.800-423-4136Currently in Shortage
- Fresenius Kabi USA, LLC888-386-1300Currently in Shortage
- Hospira, Inc., a Pfizer Company844-646-4398Currently in Shortage
- Hikma Pharmaceuticals USA, Inc.800-631-2174Currently in Shortage
- Hikma Pharmaceuticals USA, Inc.800-631-2174Currently in Shortage
- Hikma Pharmaceuticals USA, Inc.800-631-2174Currently in Shortage
- Hikma Pharmaceuticals USA, Inc.800-631-2174Currently in Shortage
- Hikma Pharmaceuticals USA, Inc.800-631-2174Currently in Shortage
- Hikma Pharmaceuticals USA, Inc.800-631-2174Currently in Shortage
- Hikma Pharmaceuticals USA, Inc.800-631-2174Currently in Shortage
- Hikma Pharmaceuticals USA, Inc.800-631-2174Currently in Shortage
Reason for shortage
Availability: Limited Availability
ad slot 300x250
Related shortages in Neurology
Valproate Sodium Injection
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/02/2026
Riluzole Oral Suspension
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
Clonazepam Tablet
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
Clonazepam Tablet
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
Riluzole Oral Suspension
- Category
- Neurology
- Reason
- Requirements related to complying with good manufacturing practices
- Updated
- 04/01/2026
Clonazepam Tablet
- Category
- Neurology
- Reason
- Not specified
- Updated
- 04/01/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.